Last Updated: November 13, 2026

Technetium tc-99m labeled carbon - Generic Drug Details

Name: technetium tc-99m labeled carbon Generic Launch, Drug Patent, and Exclusivity Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

What are the generic sources for technetium tc-99m labeled carbon and what is the scope of freedom to operate?

Technetium tc-99m labeled carbon is the generic ingredient in one branded drug marketed by Cyclomedica and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for technetium tc-99m labeled carbon

International Patents:	14
US Patents:	1
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	1
DailyMed Link:	technetium tc-99m labeled carbon at DailyMed

Recent Clinical Trials for technetium tc-99m labeled carbon

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mayo Clinic	N/A
Advanced Breath Diagnostics, LLC	N/A
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A

See all technetium tc-99m labeled carbon clinical trials

US Patents and Regulatory Information for technetium tc-99m labeled carbon

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cyclomedica	TECHNEGAS KIT	technetium tc-99m labeled carbon	AEROSOL;INHALATION	022335-001	Sep 29, 2023		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Cyclomedica	TECHNEGAS KIT	technetium tc-99m labeled carbon	AEROSOL;INHALATION	022335-001	Sep 29, 2023		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for technetium tc-99m labeled carbon

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Australia	2006200755	Improved process for the production of a radioactive aerosol	⤷ Start Trial
Australia	2011202136	Improved process for the production of a radioactive aerosol	⤷ Start Trial
Canada	2538192	PROCEDE AMELIORE POUR LA PRODUCTION D'UN AEROSOL RADIOACTIF (IMPROVED PROCESS FOR THE PRODUCTION OF A RADIOACTIVE AEROSOL)	⤷ Start Trial
China	101217983	Improved process for the production of a radioactive aerosol	⤷ Start Trial
Denmark	1745803		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for technetium tc-99m labeled carbon

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1178838	300736	Netherlands	⤷ Start Trial	PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.